InvestorsHub Logo

lesgetrich

08/16/17 7:59 PM

#17882 RE: BubbaInSC #17881

Old worn out phony claims repeated over and over...

$80 million OMHE revenue prediction debunked

Debunking phony "facts" about Omni - Omni is profitable and not diluting

More phony "facts" about omni debunked – Omni outperforms most independent pharmacies

Omni is undervalued and should be trading at $.05 to $.13 per share

regarding...

Every pharmacy has specialty pharmaceuticals. Mal-B-Gone has no exclusive distribution rights to any prescriptive medications.



...And every pharmacy buys their specialty drugs from a wholesaler like Omni. No wholesaler has exclusive rights to any drug, they have rights of first refusal on purchases from their pharmacy network. Omni is a wholesaler for the Health Mart network of pharmacies. They don't need exclusive rights when those drugs are selling from $500 to tens of thousands of dollars per fill.

Omni owns Celebcream, its website and exclusive distribution rights – the location of Malecon pharmacy is a competitive advantage

The anti-aging cream market is estimated to be worth $191.7 billion by 2019

mCig had a positive influence on Omni

Debunked claims that VitaCig shareholders got hosed

No "scummy accounting" in VitaCig-Omni purchase

Andrey didn't profit from preferred conversions

Debunked Again